Skip to main content

Bausch Health Companies Inc(BHC-T)
TSX

Today's Change
Real-Time Last Update
Day Low6.97
Day High7.33
Open:7.33
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Bausch Health Companies Inc

Select a category then submit the form to load news
Newsfile
Upcoming Meeting Dates - March 2, 2026
Newswire.ca
Bausch Health's Aesthetics Business, Solta Medical, Announces the Launch of Clear + Brilliant® Touch Laser in Canada
Newswire.ca
BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS
Baystreet
Stocks in play: Bausch Health Companies Inc.
Newswire.ca
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Baystreet
Stocks in play: Bausch Health Companies Inc.
Newswire.ca
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
Newswire.ca
Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026
Newswire.ca
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
ACCESS Newswire
Bausch Health Announces Final Results and Expiration of Exchange Offers
ACCESS Newswire
Bausch Health Announces Early Exchange Offer Results for Exchange Offers
Baystreet
Stocks in play: Bausch Health Companies Inc.
INK Research
Director buying at Bausch Health Companies (BHC)
Company Chart of BHC
ACCESS Newswire
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
ACCESS Newswire
Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes
ACCESS Newswire
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
ACCESS Newswire
Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease
Baystreet
TSX Gains by Noon
ACCESS Newswire
Bausch Health Announces Third Quarter 2025 Results
The Globe and Mail
Which S&P/TSX sectors are still undervalued?
For Number Cruncher column in Globe Investor/ROB only.
AI-generated - The Globe and Mail
Bausch Health Companies: Top 25 Undervalued Toronto Stock Exchange Stocks (BHC)
Baystreet
Stocks in play: Bausch Health Companies Inc.
ACCESS Newswire
Bausch Health Announces Results of Special Meeting of Shareholders
Baystreet
Stocks in play: Bausch Health Companies Inc.
ACCESS Newswire
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
ACCESS Newswire
Bausch Health to Announce Third Quarter 2025 Results on October 29
ACCESS Newswire
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
Baystreet
Central Bank Meetings Throw Scare into Investors
ACCESS Newswire
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
Baystreet
TSX Hangs onto Gains
ACCESS Newswire
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
ACCESS Newswire
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025

Profile

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.